KROSSLINKER Aerogel Solutions

๐Ÿ“ Singapore, Singapore๐Ÿ‘ฅ 12 employees๐Ÿ’ฐ Last funded Oct 2024
At KROSSLINKER, we innovate and transform Aerogel for challenging insulation applications. Our first product aims to serve the cold-chain biopharma packaging industry by protecting temperature-sensitive pharmaceuticals, precious biologics, and vaccines throughout their shipping journey with our transformative technology.
5
Total investors
0
Early stage
0
Mid stage
0
Late stage
โ€”
Founded
Investor geography2 countries
Singapore
4
United States
1
Investor activity2022โ€“2024 ยท investors recorded per year
2022420241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in KROSSLINKER Aerogel Solutions?
KROSSLINKER Aerogel Solutions has 5 investors on record on gritt.io.
When did KROSSLINKER Aerogel Solutions last raise funding?
The most recent investment in KROSSLINKER Aerogel Solutions recorded on gritt.io was in October 2024.
What industry is KROSSLINKER Aerogel Solutions in?
KROSSLINKER Aerogel Solutions operates in Chemical Manufacturing. Find similar Chemical Manufacturing investors on gritt.io.
Where is KROSSLINKER Aerogel Solutions based?
KROSSLINKER Aerogel Solutions is headquartered in Singapore, Singapore.